CN117064773A - Cosmetic composition with whitening effect - Google Patents
Cosmetic composition with whitening effect Download PDFInfo
- Publication number
- CN117064773A CN117064773A CN202311259779.4A CN202311259779A CN117064773A CN 117064773 A CN117064773 A CN 117064773A CN 202311259779 A CN202311259779 A CN 202311259779A CN 117064773 A CN117064773 A CN 117064773A
- Authority
- CN
- China
- Prior art keywords
- percent
- cosmetic composition
- oil
- water
- astaxanthin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 131
- 239000002537 cosmetic Substances 0.000 title claims abstract description 73
- 230000002087 whitening effect Effects 0.000 title claims abstract description 24
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 24
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 24
- 239000001168 astaxanthin Substances 0.000 claims abstract description 24
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 24
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 24
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 16
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical group CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 12
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004519 grease Substances 0.000 claims abstract description 12
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims abstract description 12
- 229940001584 sodium metabisulfite Drugs 0.000 claims abstract description 12
- 235000010262 sodium metabisulphite Nutrition 0.000 claims abstract description 12
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 10
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical group CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000003921 oil Substances 0.000 claims description 19
- 235000019198 oils Nutrition 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 239000012071 phase Substances 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 14
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 13
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 12
- 229940032094 squalane Drugs 0.000 claims description 12
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000003906 humectant Substances 0.000 claims description 10
- 229960005323 phenoxyethanol Drugs 0.000 claims description 10
- 239000003755 preservative agent Substances 0.000 claims description 10
- 230000002335 preservative effect Effects 0.000 claims description 10
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 9
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 9
- 229940036350 bisabolol Drugs 0.000 claims description 9
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 7
- 239000000043 antiallergic agent Substances 0.000 claims description 7
- 230000003750 conditioning effect Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 6
- 241000168517 Haematococcus lacustris Species 0.000 claims description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 238000010008 shearing Methods 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 229940072107 ascorbate Drugs 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 3
- 239000004320 sodium erythorbate Substances 0.000 claims description 3
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 3
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims description 2
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 206010070834 Sensitisation Diseases 0.000 claims description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 claims description 2
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- 239000004289 sodium hydrogen sulphite Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims 1
- 208000003351 Melanosis Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 10
- 230000007794 irritation Effects 0.000 abstract description 8
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical group CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 40
- 238000012360 testing method Methods 0.000 description 36
- 239000000839 emulsion Substances 0.000 description 26
- 238000009472 formulation Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 239000002245 particle Substances 0.000 description 12
- 239000013642 negative control Substances 0.000 description 7
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 239000007933 dermal patch Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 101100248253 Arabidopsis thaliana RH40 gene Proteins 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000036564 melanin content Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000002138 bisabolol group Chemical group 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- -1 parabens Chemical compound 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 238000002381 microspectrum Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses a cosmetic composition with whitening effect, which comprises 0.1-2.0% of 4-butylresorcinol, 0.01-0.5% of astaxanthin, 2.0-6.0% of grease, 0.2-5.0% of antioxidant, 0.5-5.0% of emulsifier and 100% of water. The grease is caprylic acid capric acid triglyceride; the antioxidant is selected from alpha-tocopherol acetate, ascorbyl tetraisopalmitate, sodium metabisulfite and the like; the emulsifier is selected from SIMULGEL EG, SEPIGEL305, etc. The composition has good stability, no irritation and high safety, can remarkably reduce skin melanin, has the effects of whitening and removing freckle, and is very suitable for daily skin care.
Description
Technical Field
The invention belongs to the field of cosmetics, and particularly relates to a cosmetic composition with a whitening effect and a preparation method thereof.
Background
With the improvement of living standard, people pay more attention to nursing and maintaining facial skin. Many skin care products and cosmetics with whitening and freckle removing effects are popular with consumers, and the products mainly realize the whitening effect by means of only physical covering effect, exfoliating, resisting oxidation, inhibiting melanosome transportation, inhibiting tyrosinase expression and the like.
4-butyl resorcinol can be directly combined with the active center area of tyrosinase, so that the tyrosinase activity in skin is effectively inhibited, meanwhile, the skin-care composition has good oxidation resistance, the oxidation reaction in the melanin synthesis process is inhibited, the formation of melanin is blocked, the generation of melanin is reduced from the source, the skin color is whitened, and color spots and chloasma are removed. Natural astaxanthin is a carotenoid which is not a source of vitamin a and has powerful antioxidant properties, and by scavenging free radicals, it significantly reduces melanin deposition, also known as "super vitamin E". With the discovery of the antioxidant capacity and other biological activities of astaxanthin, astaxanthin is gradually applied to the fields of health food, cosmetics, medical preparations and the like.
Although a large number of components with whitening effect are known, the preparation of cosmetic preparations with stable properties and meeting the actual demands still needs further research and development.
Disclosure of Invention
The invention aims to provide a cosmetic composition with whitening and freckle removing effects and a preparation method thereof. The composition has good stability, no irritation to skin, high safety, excellent whitening mechanism, and can remarkably reduce melanin content of skin, improve skin complexion grade, and has obvious freckle removing and whitening effects, and is suitable for daily skin care of people.
The invention provides the following technical scheme:
in a first aspect, the present invention provides a cosmetic composition, wherein the composition comprises, in weight percent: 0.1 to 2.0 percent of 4-butyl resorcinol, 0.01 to 0.5 percent of astaxanthin, 2.0 to 6.0 percent of grease, 0.2 to 5.0 percent of antioxidant, 0.5 to 5.0 percent of emulsifier and 100 percent of water.
Preferably, the composition comprises, in weight percent of the composition: 0.2 to 1.0 percent of 4-butyl resorcinol, 0.02 to 0.2 percent of astaxanthin, 3.0 to 6.0 percent of grease, 0.5 to 2.0 percent of antioxidant, 1.0 to 3.0 percent of emulsifier and 100 percent of water.
The oil is selected from one or more of caprylic/capric triglyceride, isopropyl palmitate, coconut oil, olive oil, soybean oil, tea seed oil and isooctyl stearate; preferably, the fat is caprylic capric triglyceride.
The antioxidant is selected from one or more of tocopherol, alpha-tocopherol acetate, tocopherol nicotinate, ascorbic acid, tetraisopalmitate ascorbate, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, sodium metabisulfite, sodium bisulphite, butyl hydroxy anisole and dibutyl hydroxy toluene; preferably, the antioxidant is selected from one or more of alpha-tocopherol acetate, tetraisopalmitate ascorbate and sodium metabisulfite.
The emulsifier is one or more selected from SIMULGEL EG, SEPIGEL305, SIMUGEL INS100, SEPIPLUS 400, SIMULGEL NS; preferably, the emulsifier is selected from one or both of SIMULGEL EG and SEPIGEL 305.
The astaxanthin is a commercial astaxanthin raw material and comprises 15% of haematococcus pluvialis (HAEMATOCOCCUS PLUVIALIS) oil, 15% of glycerol, 6% of PEG-100 hydrogenated castor oil, 188% of poloxamer, 3% of sodium erythorbate and 55% of water.
In some embodiments, the cosmetic compositions of the present invention further comprise one or more of a soothing anti-sensitization agent, a skin conditioning agent, a humectant, a preservative, a pH adjusting agent.
For example, the soothing anti-allergic agent is selected from bisabolol and/or panthenol; preferably, the soothing anti-allergic agent is bisabolol. The content of the relieving and anti-allergic agent is 0.2-1.0%; preferably 0.3 to 0.8%.
For example, the skin conditioning agent is squalane and/or squalane; preferably, the soothing anti-allergic agent is squalane. The content of the skin conditioning agent is 0.5-5.0%; preferably 1.0 to 3.0%.
For example, the humectant is selected from one or more of glycerin, propylene glycol, butylene glycol, sorbitol, sodium hyaluronate, allantoin; preferably, the humectant is selected from one or more of glycerin, propylene glycol, sodium hyaluronate, allantoin. The content of the humectant is 5.0-15.0%; preferably 8.0 to 12.0%.
For example, the preservative is selected from one or more of phenoxyethanol, benzyl alcohol, hexylene glycol, pentylene glycol, parabens, p-hydroxyacetophenone, and ethylhexyl glycerol; preferably, the preservative is selected from one or more of phenoxyethanol, parabens, ethylhexyl glycerol, and the like. The content of the preservative is 0.2-2.0%; preferably 0.5 to 1.5%.
For example, the pH adjuster is an acid selected from one or more of citric acid, malic acid, tartaric acid, and gallic acid, or a base selected from tromethamine and/or triethanolamine. The pH regulator is used in an amount suitable to regulate the pH of the cosmetic composition to 4.5-7.5, preferably to 5.0-7.0.
In some embodiments, one of ordinary skill in the art may further add one or more of a emollient, thickener, chelating agent, fragrance, according to common general knowledge in the art. The specific components and amounts may be selected in accordance with common general knowledge.
In some embodiments, the cosmetic composition of the present invention comprises, in weight percent, the following components: 0.1 to 1.0 percent of 4-butyl resorcinol, 0.02 to 0.2 percent of astaxanthin, 3.0 to 6.0 percent of caprylic/capric triglyceride, 0.1 to 1.0 percent of alpha-tocopherol acetate, 0.1 to 2.0 percent of ascorbyl tetraisopalmitate, 0 to 0.005 percent of sodium metabisulfite, 0.2 to 1.0 percent of bisabolol, 0.5 to 5.0 percent of squalane, 5.0 to 12.0 percent of glycerin, 0.05 to 0.5 percent of sodium hyaluronate, 0.5 to 1.5 percent of phenoxyethanol or Antimicro9010, 1.0 to 3.0 percent of SIMULMGEL EG and water to 100 percent.
In some embodiments, the cosmetic composition of the present invention comprises, in weight percent, the following components: 0.5 to 1.0 percent of 4-butyl resorcinol, 0.05 to 0.1 percent of astaxanthin, 3.0 to 5.0 percent of caprylic/capric triglyceride, 0.3 to 0.6 percent of alpha-tocopherol acetate, 0.5 to 1.0 percent of ascorbyl tetraisopalmitate, 0.003 to 0.005 percent of sodium metabisulfite, 0.3 to 0.8 percent of bisabolol, 1.0 to 3.0 percent of squalane, 8.0 to 10.0 percent of glycerin, 0.1 to 0.15 percent of sodium hyaluronate, 0.8 to 1.2 percent of phenoxyethanol or Antimicro9010, 1.5 to 2.0 percent of SIMULMEL EG and water to 100 percent.
In one exemplary embodiment, the cosmetic composition comprises the following components in weight percent: 4-butylresorcinol 0.5%, astaxanthin 0.05%, caprylic capric triglyceride 3.0-5.0%, alpha-tocopheryl acetate 0.5%, ascorbyl tetraisopalmitate 1.0%, sodium metabisulfite 0.005%, bisabolol 0.5%, squalane 2.0%, glycerol 10.0%, sodium hyaluronate 0.1%, phenoxyethanol or Antimicro 9010.0%, SIMULGEL EG 2.0%, and water to 100%.
In a second aspect, the present invention provides a method for preparing the above cosmetic composition, comprising the steps of:
1) Preparing an aqueous phase: mixing water, emulsifier, astaxanthin, humectant, and optionally other water-soluble components (if any), and stirring;
2) Preparing an oil phase: mixing 4-butylresorcinol, oil, antioxidant, and optionally other oil-soluble components (if any), and stirring well;
3) Emulsification: mixing the oil phase with the water phase, stirring for emulsification, and optionally shearing to obtain the cosmetic composition.
The above steps may be performed at room temperature. The shearing time may be 5 to 30 minutes, for example 10 minutes.
The cosmetic composition provided by the invention is an emulsion comprising 4-butylresorcinol, astaxanthin, grease, an antioxidant, an emulsifier, water and other components, has good stability, small irritation and high safety, can obviously reduce skin melanin, improve skin complexion grade, has the effects of whitening, removing freckles, locking water and moisturizing, and is suitable for long-term skin care. The preparation method of the composition provided by the invention has simple and rapid process, adopts cold-blending emulsification, does not need heating, shortens the production time, improves the production efficiency, and is more suitable for industrial production.
Detailed Description
The invention provides a cosmetic composition containing 4-butylresorcinol and astaxanthin, which has the effects of whitening, removing freckles and protecting skin. The composition is found to have poor stability in the research process, and the problems of yellowing, transparentization, particle aggregation, layering and the like of the emulsion can occur in the storage process of different formulas. The inventor researches and screens the components of the effective components, the oil phase, the water phase, the dosage thereof and the like through repeated experiments, finally obtains the composition protected by the invention, has the advantages of good stability, low irritation and high safety, and can be used for daily whitening and skin care of people.
Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. When trade names are presented herein, it is intended to refer to their corresponding commercial products or active ingredients thereof.
In the present invention, 4-butylresorcinolThe effect of reducing melanin production is achieved by inhibiting the formation of tyrosinase and tyrosinase-related protein-1.
The terms "comprising," "including," "having," "containing," or "involving," and other variations thereof herein, are inclusive or open-ended and do not exclude additional unrecited elements or method steps.
Unless otherwise indicated, the components of the present invention are present in weight percent or parts by weight.
In the invention, the content of the effective components 4-butyl resorcinol and astaxanthin in the composition can be respectively 0.1-2.0% and 0.01-0.5%; preferably, the content thereof is 0.2 to 1.0% and 0.02 to 0.2%, respectively, for example 0.5% and 0.05%, respectively. The composition with the content range has the advantages of light pink to pink appearance, attractive and stable color, obvious whitening effect, no irritation, high safety and suitability for long-term use.
The inventor discovers that the composition prepared by adopting caprylic/capric triglyceride as grease is a pink uniform emulsion through screening oil phase components, and keeps stable character in the standing process. When mineral oil, castor oil or isopropyl myristate was used as the oil, the appearance of the resulting samples was uneven or unstable after standing, indicating that these oils were unsuitable for preparing stable and homogeneous emulsion compositions. In the present invention, the preferred oil component is caprylic capric triglyceride.
Further, the present inventors have conducted screening by using an emulsifier conventionally used for emulsion. When SIMULGEL EG or SEPIGEL305 is used as the emulsifier, the composition is prepared as a pink homogeneous emulsion with stable properties. And DEMO-90V+DECAGLYN 1-OV and DECAGLLYN 1-M+RH40、When RH40+ soybean phospholipids and Pemulen TR-1+ span 80 are used as emulsifying agents respectively, the obtained emulsion composition is obviously unstable, and demulsification, transparency, layering, pH drop or particle aggregation phenomena respectively occur in a short time, so that the emulsifying agents are not suitable for preparing the cosmetic composition. In the present invention, preferred emulsifiers are SIMULTEL EG and SEPIGEL305, preferably SIMULTEL EG.
Further, the present inventors screened different types of emulsifiers, and when SIMULGEL 600 was used as an emulsifier, the emulsion composition was discolored after standing at 40℃for 14 days, and the pink color was remarkably discolored to be white-yellow; when SIMULGEL FL is used as the emulsifier, the emulsion composition turns significantly yellow and the emulsion is slightly transparent. Therefore none of the above emulsifiers are suitable for preparing the cosmetic compositions of the present invention.
In addition, the inventors also screened antioxidants to obtain the antioxidants of the invention. While testing different formulations, no stable compositions were obtained. For example, when the formulation contains 0.2% dipotassium glycyrrhizinate, the composition can be significantly demulsified and quickly discolored to yellow when left at 40 ℃ for 7 days; when the formulation contains 0.5% of p-hydroxyacetophenone, the color of the composition becomes significantly yellow; when the formula contains 0.002% of disodium ethylenediamine tetraacetate, the composition can obviously change color and become transparent during the standing process; when 0.002% magnesium ascorbyl phosphate is included in the formulation, the composition will delaminate during the rest of the composition, resulting in unstable compositions.
Particle size D of the composition of the invention 50 Is 2 to 7. Mu.m, preferably 3 to 5. Mu.m. The viscosity is 3000-6000 mPa.s. Comfortable use, easy application, and no stickiness.
The features and advantages of the cosmetic composition of the present invention will be described in further detail below with reference to specific examples. It is to be understood that the following examples are illustrative only and are not to be construed as limiting the scope of the invention. All techniques implemented based on the above description of the invention are intended to be included within the scope of the invention.
The adjuvants and reagents used in the examples below are commercially available or may be prepared by known methods. In a specific embodiment, astaxanthin is a commercially available material, available from Rui algae Biotechnology (Suzhou) Co., ltd., product number CWSE-1C, in a black red color liquid, and comprises 15% Haematococcus pluvialis (HAEMATOCOCCUS PLUVIALIS) oil, 15% glycerol, 6% PEG-100 hydrogenated castor oil, 188% poloxamer, 3% sodium erythorbate, and 55% water;
SEPIGEL305 refers to the product sold by SEPPIC corporation under the trade name SEPIGELAnd C13-14 isoparaffin (and) laurylether-7; SIMULGEL EG refers to SIMULGEL sold by SEPPIC corporation under the trade name SIMULGELSodium acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate-80; SIMUGEL FL refers to the product sold by SEPPIC company under the name SIMUGEL->Hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and isohexadecane (and) polysorbate-60; SIMULGEL 600 refers to SIMULGEL +.>Acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate-80. The preservative used in the present invention has the trade name +.>Is a compound of phenoxyethanol and ethylhexyl glycerol, and is purchased from Guangdong Dimei New Material technology Co.
The "/" in the tables of the present invention indicates that the corresponding components are not contained; or no corresponding data was measured.
The content test method of the 4-butyl resorcinol comprises the following steps: high Performance Liquid Chromatography (HPLC) method, instrument: waters Arc; chromatographic column: agilent Zorlanx-SB C18; the test conditions were as follows: column temperature: 35 ℃; flow rate: 1.0mL/min; detection wavelength: 280nm; run time: for 10min; sample injection amount: 10. Mu.L; mobile phase a phase: 0.1% formic acid-water; and B phase: acetonitrile; a diluent: 50% acetonitrile-water.
Stability investigation:
acceleration test: placing the sample in a sealed clean container, performing 6 months test at 40+ -2deg.C, sampling at 14 days, 1, 2, 3, and 6 months respectively, and comparing appearance, pH, particle size, viscosity, and content of the sample with 0 day. The sample container is an impermeable container and a glass penicillin bottle, so that the humidity condition of the test is not required. Experimental data for only a part of time points are shown in the following examples according to circumstances.
Appearance: samples were placed at different time points for visual appearance changes at 0 days and 40 ℃ ± 2 ℃ after preparation, respectively.
pH: the samples were placed in appropriate containers for use according to the direct assay in the GB/T13531 standard. Two standard buffer solutions were selected, calibrated under a temperature compensation system, the electrodes were rinsed with purified water, then blotted dry with filter paper, the electrodes carefully inserted into the sample, the electrodes immersed, and the reading recorded after the pH reading stabilized. After reading, the electrode is thoroughly cleaned for standby. The measurement result of the pH value is expressed as an average value of two measurements, and is accurate to 0.1.
Particle size: using a Markov 3000 laser diffraction particle diameter instrument, selecting a wet test, cleaning the instrument, taking 1mL of sample, putting into a dispersion tank, starting measurement after the shading degree value is stable, measuring for three times by the instrument, outputting a result, calculating an average value, recording, and selecting D 50 (μm) as sample particle size data.
Viscosity: the determination was performed using an NDJ-8S series digital viscometer. The sample is placed in a suitable container for use. And a number 4 rotor is selected according to the range table, and 30 revolutions per minute is set. After the instrument is adjusted to be horizontal, the rotor is vertically inserted into the sample through the lifting knob until the liquid level is level with the middle part of the rotor groove. And starting measurement, outputting data to be output by the instrument, recording, and representing the measurement result as the average value of the two measurements. The viscosity is preferably in the range of 3000 to 6000 mPas.
Example 1 cosmetic composition
The formulation of the cosmetic composition is shown in table 1.
The preparation method comprises the following steps:
1) Preparing an oil phase: according to the formula shown in Table 1, 4-butyl resorcinol, grease (caprylic/capric triglyceride), antioxidant (alpha-tocopherol acetate, ascorbyl tetraisopalmitate), skin conditioner (squalane) and preservative (Antimicro 9010) are stirred and dissolved at room temperature, and are uniformly dispersed;
2) Preparing an aqueous phase: dispersing emulsifier (SIMULGEL EG) in all or part of water according to the formula shown in table 1, adding astaxanthin, humectant (glycerin) and optional other water-soluble components (such as sodium metabisulfite), and stirring uniformly;
3) Emulsification: adding the oil phase into the water phase, stirring for 30min, optionally adding water to the prescribed amount, and shearing for 10min to obtain the cosmetic composition in the form of emulsion.
TABLE 1 formulation of cosmetic compositions
The experimental results show that the emulsion compositions of the formulas 1 to 3 are respectively placed at 40 ℃ for 6 months, have no obvious change in appearance, are pink uniform emulsion, have no granular feel and layering phenomenon, and have no obvious change in particle size. The pH of the composition remained stable and did not change significantly. The viscosity is basically kept stable without obvious change. The emulsion compositions of formulas 1-3 have good stability.
Example 2 cosmetic composition
The formulation of the cosmetic composition is shown in table 2.
The preparation method comprises the following steps: reference is made to example 1.
TABLE 2 formulation of cosmetic compositions
The experimental results show that the emulsion composition of the formula 4-the formula 6 has no obvious change in appearance after being placed for 6 months at 40 ℃, is light pink uniform emulsion, has no granular feel and layering phenomenon, and has no obvious change in particle size. The pH of the composition remained stable without significant changes. The viscosity is basically kept stable without obvious change. The content of 4-butyl resorcinol is stable. The emulsion compositions of formulas 4-6 have good stability.
Example 3 cosmetic composition
The formulation of the cosmetic composition is shown in table 3.
The preparation method comprises the following steps: reference is made to example 1.
TABLE 3 formulation of cosmetic compositions
The experimental results show that the emulsion composition of the formula 7-the formula 9 has no change in appearance after being placed for 6 months at 40 ℃, is light pink uniform emulsion, has no granular feel and layering phenomenon, and has no obvious change in particle size. The pH of the composition remained stable and did not change significantly. The viscosity is kept stable without obvious change. The content of 4-butyl resorcinol is stable. The emulsion compositions of formulas 7-9 have good stability.
Comparative example 1 cosmetic composition
Formulations 10 to 12 of the cosmetic compositions are shown in Table 4.
The preparation method comprises the following steps: reference is made to example 1.
TABLE 4 formulation of cosmetic compositions
The compositions of formulas 10 to 12 respectively adopt mineral oil, castor oil and isopropyl myristate which are conventionally used in emulsion as grease, and experimental results show that the appearance of the compositions is obviously changed, the properties are uneven or unstable after the compositions are placed at normal temperature of 25 ℃ or 40 ℃ for a short time, so that the grease is not suitable for being used in the cosmetic composition of the invention. The preferred oil component of the present invention is caprylic capric triglyceride.
Comparative example 2 cosmetic composition
Formulations 13 to 16 of the cosmetic compositions are shown in Table 5.
The preparation method comprises the following steps: reference is made to example 1.
TABLE 5 formulation of cosmetic compositions
The compositions of formulas 16-18 respectively adopt DEMO-90V+DECAGLYN 1-OV and DECAGLYN 1-M +
RH40、As the result of experiments, RH40+ soybean phosphatide and Pemulen TR-1+ span 80 are used as emulsifying agents, and the obtained emulsion composition is obviously unstable and has the phenomena of demulsification, transparency, layering, pH drop or particle aggregation respectively in a short time. Therefore, these emulsifiers are not suitable for use in the cosmetic compositions of the present invention.
Comparative example 3 cosmetic composition
Formulations 17 to 19 of the cosmetic compositions are shown in Table 6.
The preparation method comprises the following steps: reference is made to example 1.
TABLE 6 formulation of cosmetic compositions
Formulas 17-19 further examined the effect of different emulsifier types on cosmetic compositions. The experimental result shows that when SIMULGEL 600 is used as an emulsifier, the emulsion composition changes color after being placed for 14 days at 40 ℃, the pink color obviously changes into white yellow; when SIMULGEL FL is used as the emulsifier, the emulsion composition turns significantly yellow and the emulsion is slightly transparent; when SEPIGEL305 was used as the emulsifier, the emulsion composition turned slightly yellow. Formulations 17-19 remained stable for a relatively long period of time at ambient conditions (data not shown), but were less stable at 40 ℃. In the present invention, the emulsifier SEPIGEL305 is an optional emulsifier, but a preferred emulsifier is simullel EG.
Test example 1 skin patch test
The cosmetic composition of the present invention was subjected to a human skin patch test for safety and irritation. The test is entrusted to a third party analysis and detection organization (Shanghai micro-spectrum detection technology group).
1. Materials and methods
1. Test article: cosmetic composition formulation 8
2. Negative control: blank + filter control
3. The subject: 30 persons total, male 1 person, female 29 person, age 26-60 years, average age 47.57+ -8.75 years, meet the volunteer selection criteria of the subjects.
4. Plaque test method: selecting qualified plaque test equipment, placing 0.020-0.025 ml of test object into plaque test equipment by a closed type banon test method, applying a hyposensitization tape to the forearm curved side of a subject, removing the test object 24 hours later, observing skin reaction respectively 0.5, 24 and 48 hours later, and recording the result according to the skin reaction grading standard in cosmetic safety technical Specification (2015).
2. Test results
The skin response grading criteria for the skin closed patch test are shown in Table 7. The results of the human skin patch test are shown in Table 8.
TABLE 7 skin response grading Standard for skin closed Patch test
TABLE 8 human skin patch test results
The test results of the human skin patch show that all subjects do not have skin adverse reactions, so that the cosmetic composition provided by the invention has no irritation to skin, is high in safety, and is suitable for daily skin care.
Test example 2 whitening and freckle-removing efficacy test of cosmetic composition
The present test example conducted a whitening and freckle-removing efficacy test on the cosmetic composition of the present invention.
1. Materials and methods
1. Test article: cosmetic composition of inventive formulation 8
2. Negative control: blank control
3. Positive control: 7% of ascorbic acid (vitamin C) products are prepared according to the formula of annex I of a cosmetic freckle removing and whitening efficacy test method-a first method ultraviolet-induced human skin blackening model freckle removing and whitening efficacy test method in cosmetic safety technical Specification (2015 edition).
4. The subject: 30 people total, 10 men, 20 women, 18-54 years of age, and average age of 36.10+/-12.41 years, and meet the volunteer selection standard of the subjects.
5. The test method comprises the following steps: the test was carried out according to the specific requirements of cosmetic safety Specification (2015 edition). Selecting the back of the subject as the test area not smaller than 0.5cm 2 And should be located within each of the application areas. MED of the test site of the subject is determined. The same irradiation spot was irradiated with a day 1 with 0.75 times MED dose for 4 consecutive days using a solar simulator. The 4 days after the end of irradiation are skin darkening periods without any treatment. On the 5 th day after the irradiation, the skin of each test area is smeared with corresponding test objects according to a random table, and the test objects are connectedThe subjects were continuously applied for at least 4 weeks, and the skin color was visually evaluated and instrumentally detected at 1 week, 2 weeks, 3 weeks and 4 weeks after the application, and the ITA value (representing the darkness of skin color), MI value (representing the melanin content of skin) and visual skin color grade improvement degree were detected, respectively, and were statistically analyzed, wherein one item having significance compared with the negative control group was considered to have a whitening effect.
2. Test results
Statistical analysis results of ITA DEG and MI at each time point before and after the use of each group of samples are shown in Table 9; the results of the statistical analysis of the improvement degree of the visual skin tone grade are shown in Table 10.
TABLE 9 statistical analysis results of ITA℃and MI at various time points before and after use
Note that: compared with the negative control group, the MI value regression coefficient P of the formula 8 is less than 0.05, and has significant difference.
TABLE 10 statistical analysis of visual skin tone grade improvement levels at various time points before and after use
Note that: compared with a negative control group, the visual skin color grade regression coefficient P of the formula 8 is less than 0.05, and has a significant difference.
The experimental result shows that the product of the formula 8 has an effect of improving the skin depth; the improvement degree of the MI value of the skin is obviously better than that of a negative control group in weeks 2, 3 and 4, and has obvious difference, so that the composition of the invention can obviously reduce the melanin content in the skin; the degree of improvement in the visual complexion grade of the skin was significantly better at weeks 3 and 4 than the negative control group, indicating that the composition of the invention can significantly improve the skin complexion. In summary, the composition of the invention has remarkable whitening effect.
The inventor performs extensive experimental study on various components and proportions in the composition formula, and performs screening, testing and comparison through a large number of experiments to obtain the cosmetic composition with the whitening and freckle removing effects. The composition can be placed for 6 months at high temperature, does not generate obvious color change, does not generate adverse phenomena such as demulsification, layering, particle aggregation and the like, can keep long-term stability of the cosmetic composition at normal temperature of 25 ℃, and has very good stability. In addition, the human body experiment result shows that the cosmetic composition formula of the invention does not generate irritation to skin after being used, has good safety, can obviously reduce the black content of the skin, obviously improve the skin complexion grade, and has obvious freckle removing and whitening effects.
The above examples and test examples are merely illustrative of the features and advantages that the cosmetic compositions of the present invention possess. Various modifications and substitutions of the described embodiments will occur to those skilled in the art without the need for inventive faculty in view of the present disclosure, and are intended to be included within the scope of the following claims without departing from the spirit and principles of the invention.
Claims (10)
1. A cosmetic composition with whitening effect comprises the following components in percentage by weight: 0.1 to 2.0 percent of 4-butyl resorcinol, 0.01 to 0.5 percent of astaxanthin, 2.0 to 6.0 percent of grease, 0.2 to 5.0 percent of antioxidant, 0.5 to 5.0 percent of emulsifier and 100 percent of water.
2. The cosmetic composition of claim 1, wherein the oil is selected from one or more of caprylic capric triglyceride, isopropyl palmitate, coconut oil, olive oil, soybean oil, tea seed oil, isooctyl stearate; the antioxidant is selected from one or more of tocopherol, alpha-tocopherol acetate, tocopherol nicotinate, ascorbic acid, tetraisopalmitate ascorbate, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, sodium metabisulfite, sodium bisulphite, butyl hydroxy anisole and dibutyl hydroxy toluene; the emulsifier is selected from one or more of SIMULGEL EG, SEPIGEL305, SIMUGEL INS100, SEPIPLUS 400, SIMULGEL NS.
3. The cosmetic composition of claim 1, comprising the following components in weight percent: 0.2 to 1.0 percent of 4-butyl resorcinol, 0.02 to 0.2 percent of astaxanthin, 3.0 to 6.0 percent of grease, 0.5 to 2.0 percent of antioxidant, 1.0 to 3.0 percent of emulsifier and 100 percent of water.
4. A cosmetic composition according to any one of claims 1 to 3 wherein the oil is caprylic capric triglyceride; the antioxidant is selected from one or more of alpha-tocopherol acetate, ascorbyl tetraisopalmitate and sodium metabisulfite; the emulsifier is selected from one or both of SIMULGEL EG and SEPIGEL 305.
5. The cosmetic composition of any one of claims 1-4, further comprising one or more of a soothing anti-sensitization agent, a skin conditioning agent, a moisturizing agent, a preservative, a pH adjuster.
6. The cosmetic composition of claim 5, wherein the soothing anti-allergic agent is selected from the group consisting of bisabolol and panthenol; the skin conditioning agent is selected from squalane and squalane; the humectant is one or more selected from glycerol, propylene glycol, butanediol, sorbitol, sodium hyaluronate and allantoin; the preservative is one or more selected from phenoxyethanol, benzyl alcohol, hexanediol, pentanediol, p-hydroxybenzoates and p-hydroxyacetophenone; the pH regulator is acid or alkali.
7. The cosmetic composition of claim 6, wherein the cosmetic composition comprises, in weight percent: 0.2 to 1.0 percent of release anti-allergic agent, 0.5 to 5.0 percent of skin conditioning agent, 5.0 to 15.0 percent of humectant and 0.2 to 2.0 percent of preservative;
preferably, the cosmetic composition comprises: 0.3 to 0.8 percent of release anti-allergic agent, 1.0 to 3.0 percent of skin conditioning agent, 8.0 to 12.0 percent of humectant and 0.5 to 1.5 percent of preservative.
8. The cosmetic composition according to any one of claims 1 to 7, comprising, in weight percent: 0.2 to 1.0 percent of 4-butyl resorcinol, 0.02 to 0.2 percent of astaxanthin, 3.0 to 6.0 percent of caprylic/capric triglyceride, 0.1 to 1.0 percent of alpha-tocopherol acetate, 0.1 to 2.0 percent of ascorbyl tetraisopalmitate, 0 to 0.005 percent of sodium metabisulfite, 0.2 to 1.0 percent of bisabolol, 0.5 to 5.0 percent of squalane, 5.0 to 12.0 percent of glycerin, 0.05 to 0.5 percent of sodium hyaluronate, 0.5 to 1.5 percent of phenoxyethanol or Antimicro9010, 1.0 to 3.0 percent of SIMULMEL EG and water to 100 percent;
preferably, the cosmetic composition comprises the following components in weight percent: 0.5 to 1.0 percent of 4-butyl resorcinol, 0.05 to 0.1 percent of astaxanthin, 3.0 to 5.0 percent of caprylic/capric triglyceride, 0.3 to 0.6 percent of alpha-tocopherol acetate, 0.5 to 1.0 percent of ascorbyl tetraisopalmitate, 0.003 to 0.005 percent of sodium metabisulfite, 0.3 to 0.8 percent of bisabolol, 1.0 to 3.0 percent of squalane, 8.0 to 10.0 percent of glycerin, 0.1 to 0.15 percent of sodium hyaluronate, 0.8 to 1.2 percent of phenoxyethanol or Antimicro9010, 1.5 to 2.0 percent of SIMULMEL EG and water to 100 percent;
preferably, the cosmetic composition comprises the following components in weight percent: 4-butylresorcinol 0.5%, astaxanthin 0.05%, caprylic capric triglyceride 3.0-5.0%, alpha-tocopheryl acetate 0.5%, ascorbyl tetraisopalmitate 1.0%, sodium metabisulfite 0.005%, bisabolol 0.5%, squalane 2.0%, glycerol 10.0%, sodium hyaluronate 0.1%, phenoxyethanol or Antimicro 9010.0%, SIMULGEL EG 2.0%, and water to 100%.
9. The cosmetic composition of any one of claims 1 to 8, wherein the astaxanthin comprises 15% haematococcus pluvialis (HAEMATOCOCCUS PLUVIALIS) oil, 15% glycerol, 6% PEG-100 hydrogenated castor oil, 188% poloxamer, 3% sodium erythorbate, 55% water.
10. A method of preparing the cosmetic composition of any one of claims 1 to 9, comprising the steps of:
1) Preparing an aqueous phase: mixing water, emulsifier, astaxanthin, humectant and optionally other water-soluble components, and stirring uniformly;
2) Preparing an oil phase: mixing 4-butyl resorcinol, grease, antioxidant and optionally other oil-soluble components, and uniformly stirring;
3) Emulsification: mixing the oil phase with the water phase, stirring, emulsifying, and shearing to obtain the cosmetic composition.
Preferably, the above steps are performed at room temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311259779.4A CN117064773A (en) | 2023-09-27 | 2023-09-27 | Cosmetic composition with whitening effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311259779.4A CN117064773A (en) | 2023-09-27 | 2023-09-27 | Cosmetic composition with whitening effect |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117064773A true CN117064773A (en) | 2023-11-17 |
Family
ID=88704369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311259779.4A Pending CN117064773A (en) | 2023-09-27 | 2023-09-27 | Cosmetic composition with whitening effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117064773A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118806674A (en) * | 2024-06-18 | 2024-10-22 | 妆莱(广州)生化科技有限公司 | Preparation method of highly active Tripterygium wilfordii extract and its care products and applications |
-
2023
- 2023-09-27 CN CN202311259779.4A patent/CN117064773A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118806674A (en) * | 2024-06-18 | 2024-10-22 | 妆莱(广州)生化科技有限公司 | Preparation method of highly active Tripterygium wilfordii extract and its care products and applications |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1761450B (en) | Skin external preparation characterized by containing saccharide derivative of alpha, alpha-trehalose | |
KR101823036B1 (en) | Inhibitor of melanin synthesis and the cosmetic composition containing the same | |
US4983382A (en) | Cosmetic preparation incorporating stabilized ascorbic acid | |
CN108125803B (en) | A whitening and freckle-removing composition | |
JP2000095663A (en) | Agent for external use containing plant extract | |
US8298555B2 (en) | Color cosmetic compositions for topical anti-aging skin treatment | |
CN1913869B (en) | Anti-wrinkle cosmetic | |
JPS6248611A (en) | External preparation for skin | |
KR101917774B1 (en) | A preservative composition of cosmetics comprising Nigella sativa seed extract as an active ingredient | |
CN117064773A (en) | Cosmetic composition with whitening effect | |
CN113116782B (en) | Anti-allergy repairing composition and preparation method and application thereof | |
JPH07101844A (en) | Multilayered emulsion | |
CA1325774C (en) | Cosmetic preparation incorporating stabilized ascorbic acid | |
JPH1036246A (en) | Suppressant for melanogenesis and preparation for external use for skin | |
KR102354352B1 (en) | Oil-in- water cosmetic composition comprising physical sunscreen | |
JPH01249714A (en) | Skin cosmetic | |
JP5000964B2 (en) | Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression | |
JPWO2015064681A1 (en) | Composition for external use | |
JP2002370962A (en) | Bleaching preparation and cosmetic for preventing and improving aging of skin | |
CN105310918A (en) | Green bonnie flower extract and applications thereof | |
JPS6270309A (en) | Skin beautifying cosmetic | |
CN115400067A (en) | Whitening composition for skin | |
KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
KR100823113B1 (en) | UV protection cosmetic composition | |
JP2005239623A (en) | Agent for ameliorating microvillus-like protrusion of keratinocyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |